76978-101-08 : NDC 2026 Code

76978-101-08 : Dihydroergotamine Mesylate ( Atzumi )

Additionally :

You can get information about “76978-101-08” NDC code in 76978-101-08 in HTML format

HTML | 76978-101-08 in TXT (Plain Text) format

TXT | 76978-101-08 in PDF (Portable Document Format)

PDF | 76978-101-08 in XML format

XML formats.

NDC Code : 76978-101-08 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "76978-101-08",
    "PackageDescription": "8 BOTTLE, UNIT-DOSE in 1 CARTON (76978-101-08)  / 1 POWDER in 1 BOTTLE, UNIT-DOSE",
    "NDC11Code": "76978-0101-08",
    "ProductNDC": "76978-101",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Atzumi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dihydroergotamine Mesylate",
    "DosageFormName": "POWDER",
    "RouteName": "NASAL",
    "StartMarketingDate": "20250430",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA217901",
    "LabelerName": "Satsuma Pharmaceuticals, Inc.",
    "SubstanceName": "DIHYDROERGOTAMINE MESYLATE",
    "StrengthNumber": "5.2",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Ergotamine Derivative [EPC], Ergotamines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-05-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250430",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}